251 286 - Biotech Bayern
251 286 - Biotech Bayern
251 286 - Biotech Bayern
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
CRELUX GmbH<br />
BIOTECH DNA/PROTEIN ANALYTICS<br />
Keywords: 3 D Structural Analysis<br />
CRELUX provides fast and affordable access to co-crystal structures of your<br />
compounds in complex with their protein targets. Crystallization conditions of<br />
numerous relevant therapeutic targets have been established at CRELUX.<br />
Co-crystal structures of these targets in complex with your compounds of<br />
interest will be delivered at a fixed price with a typical turn around time of six<br />
to eight weeks.<br />
At CRELUX we do everything to protect your most important asset: compound<br />
IP. We are entirely dedicated to solving client structures and don't perform any<br />
internal screening and drug discovery activities. Please enquire to find out if<br />
structural services for your targets of interest are available from CRELUX.<br />
CRENANO GmbH<br />
BIOTECH DEVICES & REAGENTS<br />
Keywords: New Materials, Devices<br />
CRENANO GmbH has developed the JETHAMMER, a novel device for microbial<br />
disruption, water treatment and the generation of emulsions and nano particles.<br />
The technology makes use of the energies set free by hydrodynamic cavitation.<br />
Moderate hydrostatic pressure (5 to 10 bar) is used to induce controlled three<br />
dimensional zones of supercavitation that can readily be adjusted to disrupt<br />
micro organisms, crush particles down to nano metre scales and generate stable<br />
emulsions. The JETHAMMER operates in a in a flow through process allowing<br />
flow rates of up to 50m3 /h. CRENANO is the sole supplier of JETHAMMER<br />
and offers the full system engineering for the integration of the device into<br />
industrial production processes and water circuits.<br />
CRO-PHARMANET SERVICES GmbH<br />
CRO<br />
Keywords: Drug Development, Antibody, Antisense/Nucleotides, Small Molecules,<br />
Vaccines, Analysis, Clinical Research<br />
PharmaNet Development Group, a global, drug development services company,<br />
provides clinical development services including consulting, Phase I and bioequivalence<br />
clinical studies, Phase II-III clinical development programs, Phase<br />
IIIb-IV surveys, registries, and programs, as well as bioanalytical laboratory<br />
services through its subsidiaries Anapharm, Anapharm Europe, Keystone<br />
Analytical, and Taylor Technology.<br />
Contact:<br />
Sonja Knoth<br />
Am Klopferspitz 19a<br />
D-82152 Martinsried<br />
Phone: +49 (0) 89 700 760-170<br />
E-Mail: schaeffer@crelux.com<br />
Internet: www.crelux.com<br />
Contact:<br />
Sonja Knoth<br />
Am Klopferspitz 19a<br />
D-82152 Martinsried<br />
Phone: +49 (0) 89 700760170<br />
Fax: +49 (0) 89 700760222<br />
E-Mail: schaeffer@crenano.com<br />
Internet: www.creanano.com<br />
Contact:<br />
Dr. Tobias Schmidt<br />
Pionierstr. 2 / KIM<br />
D-82152 Krailling<br />
Phone: +49 (0) 89 895577-77<br />
Fax: +49 (0) 89 895577-99<br />
E-Mail: tschmidt@pharmanet.com<br />
Internet: www.pharmanet.com<br />
55